Success Stories: In Just 13 Days, EB1-A Approval Won for an Indian Postdoctoral Research Associate in Cardiovascular Disease with Over 1,000 Citations, Thanks to Premium Processing and Our Teamwork

Client’s Testimonial:

“Thank you again for your help.”

On November 1^st, 2022, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Associate in the Field of Cardiovascular Disease (Approval Notice).

General Field: Cardiovascular Disease

Position at the Time of Case Filing: Postdoctoral Research Associate

Country of Origin: India

State of Residence at the Time of Filing: Virginia

Approval Notice Date: November 1^st, 2022

Processing Time: 13 days (Premium Processing Requested)

Case Summary:

An EB1-A (Alien of Extraordinary Ability) client from India won approval in just 13 days, thanks to our diligent teamwork on his case preparation and the premium processing upgrade that he opted for. Since the EB1-A is a kind of employment-based immigrant visa designed for foreign individuals who are specialized in a certain chosen area of work, our team made sure that his case was built on the merits of his achievements thus far. Some of the data our team collected for this petition are as follows:

He is one of the few leading experts in cardiovascular diseases, and he has achieved a consistent and notable record of success and influence in this area of study. He is especially well-known for the development of mitochondria-targeted drug delivery for atherosclerosis, the pathogenesis of atherosclerotic lesions, and the use of metformin for treating atherosclerosis.
He has conducted at least 25 reviews for journals that include international scientific journals of repute.
His work has also resulted in 25 peer-reviewed scientific articles. It is clear not only that he is conducting important original research, but that his work is considered majorly significant by the editors of the top journals in the field.
Due to its great applicability in the field, his research in cardiovascular diseases has been cited a massive total of 1,134 times in 56 countries all over the world according to Google Scholar.
His research on metformin as an anti-aging drug and its implementation in his peers’ studies positions his work as a major contribution to the field of cardiovascular diseases. Furthermore, his study has received funding from the Government of India’s Ministry of Science & Technology.
And we also gathered letters of recommendation from over 4 experts who had followed his work over the years. One of them said:

“[The client’s] expertise in the examination of cardiovascular disease and the onset of atherosclerosis has produced a revolutionary method of reducing the damaging formation of plaque. By introducing an effective treatment of cardiovascular disease, the United States stands to make a sizable cut in financial losses, particularly with reduced rates of hospitalization, shortened use of health care services, and lower death rates resulting in better national productivity.”

It was these details that helped make the case a convincing one winning the approval quickly. We are proud to have worked with him and we wish him the best of luck in his future endeavors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.